Showing results (1441-1450 of 2,887) with videos related to
Sort By:
Pageof 289
Parasite Immunology|August 4, 2009
Depleted intestinal goblet cells and severe pathological changes in SCID mice infected with Heligmosomoides polygyrusK Hashimoto, R Uchikawa, T Tegoshi, et al.Journal of Clinical & Laboratory Immunology|May 1, 1990
A high density cell culture system for generation of human lymphokine-activated killer (LAK) cells for clinical use in adoptive immunotherapyK Shimizu, K Park, M Yamada, et al.Stroke|August 1, 1996
Impaired autoregulation in an experimental model of chronic cerebral hypoperfusion in ratsK Irikura, S Morii, Y Miyasaka, et al.Experimental Hematology|February 1, 1996
Binding of macrophage colony-stimulating factor to serum proteinsT Ohtsuki, K Hatake, M Ikeda, et al.Experimental Hematology|February 1, 1996
Macrophage colony-stimulating factor induces interleukin-8 production in human monocytesS Hashimoto, M Yoda, M Yamada, et al.Advances in Experimental Medicine and Biology|January 1, 1995
Expression of human cathepsin E in methylotrophic yeast, Pichia pastorisM Yamada, T Matsuba, T Azuma, et al.Cancer Research|June 15, 1996
DT-diaphorase as a critical determinant of sensitivity to mitomycin C in human colon and gastric carcinoma cell linesK Mikami, M Naito, A Tomida, et al.Journal of Animal Science|February 1, 1997
Effect of oxygen concentration and free radicals on in vitro development of in vitro-produced bovine embryosY Fujitani, K Kasai, S Ohtani, et al.The British Journal of Dermatology|July 22, 2014
Clindamycin phosphate 1·2%-benzoyl peroxide 3·0% fixed-dose combination gel has an effective and acceptable safety and tolerability profile for the treatment of acne vulgaris in Japanese patients: a phase III, multicentre, randomised, single-blinded, active-controlled, parallel-group studyM Kawashima, H Hashimoto, A B Alió Sáenz, et al.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|October 1, 1989
An analogue of thyrotropin-releasing hormone, DN1417, decreases naloxone binding in the rat brainM Mori, T Michimata, H Ishihara, et al.Pageof 289